DiscoverPOLITICO's Pulse CheckSome drug patents in the Biden administration's crosshairs
Some drug patents in the Biden administration's crosshairs

Some drug patents in the Biden administration's crosshairs

Update: 2023-12-08
Share

Description

The White House says it can use "march-in rights" to seize patents for certain medicines partly developed with federal funds. Host Katherine Ellen Foley talks with POLITICO White House Correspondent Adam Cancryn about how the move could give the president another tool in his effort to lower drug prices.


Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Some drug patents in the Biden administration's crosshairs

Some drug patents in the Biden administration's crosshairs

POLITICO